Close Menu

NEW YORK (GenomeWeb) – German genetic testing firm CeGaT said today that it has received €500,000 ($531,615) from the German Federal Ministry of Education and Research to support the development of liquid biopsy methods for the analysis of circulating tumor DNA.

The funding comes from an initiative called the KMU-Innovativ: Biotechnologie-BioChance.

According to CeGaT, the money will help it expand its genetic analysis services to new patients who would currently be ineligible because they cannot safely undergo a tissue biopsy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.